Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer
- PMID: 279931
- PMCID: PMC336151
- DOI: 10.1073/pnas.75.9.4538
Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer
Abstract
A study has been made of the survival times of 100 terminal cancer patients who were given supplemental ascorbate, usually 10 g/day, as part of their routine management and 1000 matched controls, similar patients who had received the same treatment except for the ascorbate. The two sets of patients were in part the same as those used in our earlier study [Cameron, E. & Pauling, L. (1976) Proc. Natl. Acad. Sci. USA 73, 3685-3689]. Tests confirm that the ascorbate-treated patients and the matched controls are representative subpopulations of the same population of "untreatable" patients. Survival times were measured not only from the date of "untreatability" but also from the precisely known date of first hospital attendance for the cancer that eventually reached the terminal stage. The ascorbate-treated patients were found to have a mean survival time about 300 days greater than that of the controls. Survival times greater than 1 yr after the date of untreatability were observed for 22% of the ascorbate-treated patients and for 0.4% of the controls. The mean survival time of these 22 ascorbate-treated patients is 2.4 yr after reaching the apparently terminal stage; 8 of the ascorbate-treated patients are still alive, with a mean survival time after untreatability of 3.5 yr.
Similar articles
-
Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.Int J Toxicol. 2005;24 Suppl 2:51-111. doi: 10.1080/10915810590953851. Int J Toxicol. 2005. PMID: 16154915 Review.
-
Ascorbic acid in the prevention and treatment of cancer.Altern Med Rev. 1998 Jun;3(3):174-86. Altern Med Rev. 1998. PMID: 9630735 Review.
-
Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate.Int J Vitam Nutr Res Suppl. 1982;23:103-13. Int J Vitam Nutr Res Suppl. 1982. PMID: 6811475 Clinical Trial.
-
Innovation vs. quality control: an 'unpublishable' clinical trial of supplemental ascorbate in incurable cancer.Med Hypotheses. 1991 Nov;36(3):185-9. doi: 10.1016/0306-9877(91)90127-k. Med Hypotheses. 1991. PMID: 1787807 Clinical Trial.
-
Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9. doi: 10.1073/pnas.73.10.3685. Proc Natl Acad Sci U S A. 1976. PMID: 1068480 Free PMC article.
Cited by
-
Network pharmacology and molecular docking technology for exploring the effect and mechanism of high-dose vitamin c on ferroptosis of tumor cells: A review.Medicine (Baltimore). 2024 May 17;103(20):e38189. doi: 10.1097/MD.0000000000038189. Medicine (Baltimore). 2024. PMID: 38758839 Free PMC article. Review.
-
A Bioinspired Flexible Sensor for Electrochemical Probing of Dynamic Redox Disequilibrium in Cancer Cells.Adv Sci (Weinh). 2023 Dec;10(36):e2304079. doi: 10.1002/advs.202304079. Epub 2023 Nov 9. Adv Sci (Weinh). 2023. PMID: 37943018 Free PMC article.
-
Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer.Antioxidants (Basel). 2023 Aug 29;12(9):1683. doi: 10.3390/antiox12091683. Antioxidants (Basel). 2023. PMID: 37759986 Free PMC article.
-
Expected and Unexpected Effects of Pharmacological Antioxidants.Int J Mol Sci. 2023 May 26;24(11):9303. doi: 10.3390/ijms24119303. Int J Mol Sci. 2023. PMID: 37298254 Free PMC article. Review.
-
Vitamin C: From nutrition to oxygen sensing and epigenetics.Redox Biol. 2023 Jul;63:102753. doi: 10.1016/j.redox.2023.102753. Epub 2023 May 27. Redox Biol. 2023. PMID: 37263060 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources